about
Systemic Chemotherapy in Advanced Pancreatic CancerQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancerThe Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype.Risk factors and therapeutic targets in pancreatic cancer.Advanced stage pancreatic cancer: novel therapeutic options.SMAD4 and its role in pancreatic cancer.Effects of siRNA-Mediated Knockdown of HDAC1 on the Biological Behavior of Esophageal Carcinoma Cell Lines.The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion.Desmoplasia in pancreatic cancer. Can we fight it?Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.MiR-193b regulates early chondrogenesis by inhibiting the TGF-beta2 signaling pathway.A correlation study of the expression of HA-CD44st and HER-2 in breast cancerNovel CD44-downstream signaling pathways mediating breast tumor invasion
P2860
Q26750440-13597AFE-B82B-431B-A2C5-13A6DFC4303EQ30576595-2FFF7550-EDA8-42DB-B77E-90C76CBC1918Q33718622-AB9A9801-4538-4155-8ABE-42970060B1EAQ35726483-6936D369-FCFD-4DD6-B5B6-94B42968E357Q35854002-C83320E1-6D78-4141-913D-A6C344511A2BQ37273999-3DCBD775-9DF4-4F50-BF53-D69BFE85E334Q37317310-4F7275D3-BFF7-4A43-B55E-30CBF9AB2B72Q38221089-C21A8BF2-BFF3-4D71-921C-41E8A8D1378FQ38281261-9AE3CD5F-145A-431D-B4F0-4B1AB17EAC0FQ38777537-3773931E-09CC-43B7-A4CF-C97BAD14C096Q38788923-494F916B-5C99-49BC-B2BD-30A924621281Q38846822-2E0C0C11-5E49-4312-8FC1-A83C07545A92Q39103885-8D73E07B-9727-491A-AB99-D8BBB01D0D7EQ41597479-72B732EE-5F8E-4D08-BE2E-BA9BB29EAF97Q45017154-817DABC8-4E97-4662-AF2C-DB027AD0BB6BQ54172438-D2A1D4B0-05B5-49C2-8ACB-AF3127088CF6Q58754066-755AF9DB-DBBF-4A58-8E15-FD40BE96586CQ59137664-8B66E719-BA6E-4FEC-8AD2-B9BF29D812F2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transforming growth factor beta in pancreatic cancer.
@en
Transforming growth factor beta in pancreatic cancer.
@nl
type
label
Transforming growth factor beta in pancreatic cancer.
@en
Transforming growth factor beta in pancreatic cancer.
@nl
prefLabel
Transforming growth factor beta in pancreatic cancer.
@en
Transforming growth factor beta in pancreatic cancer.
@nl
P1476
Transforming growth factor beta in pancreatic cancer.
@en
P2093
Andreas Hilbig
Helmut Oettle
P304
P356
10.2174/138920111798808356
P577
2011-12-01T00:00:00Z